Q3 2024 EPS Estimates for DENTSPLY SIRONA Inc. Lowered by Leerink Partnrs (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Equities researchers at Leerink Partnrs decreased their Q3 2024 earnings per share estimates for DENTSPLY SIRONA in a report released on Monday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will earn $0.48 per share for the quarter, down from their prior forecast of $0.49. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.99 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's FY2024 earnings at $1.96 EPS, Q1 2025 earnings at $0.45 EPS, Q2 2025 earnings at $0.55 EPS, Q3 2025 earnings at $0.62 EPS, Q4 2025 earnings at $0.68 EPS, FY2025 earnings at $2.28 EPS, FY2026 earnings at $2.57 EPS and FY2027 earnings at $2.85 EPS.

Other research analysts have also issued research reports about the stock. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research report on Monday, July 22nd. Evercore ISI reduced their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. Needham & Company LLC reissued a "buy" rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Barrington Research reaffirmed an "outperform" rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Finally, Stifel Nicolaus dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a research note on Thursday, July 18th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Moderate Buy" and a consensus price target of $33.22.

DENTSPLY SIRONA Stock Performance

XRAY stock traded up $0.33 on Wednesday, reaching $24.64. 4,811,332 shares of the company were exchanged, compared to its average volume of 3,000,733. The firm has a market capitalization of $4.99 billion, a PE ratio of -28.65, a PEG ratio of 1.17 and a beta of 1.00. DENTSPLY SIRONA has a 12 month low of $23.58 and a 12 month high of $37.60. The stock's fifty day moving average price is $25.27 and its 200 day moving average price is $26.88. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. During the same quarter in the previous year, the company earned $0.51 EPS. DENTSPLY SIRONA's revenue for the quarter was down 4.3% compared to the same quarter last year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.60%. The ex-dividend date was Friday, September 27th. DENTSPLY SIRONA's payout ratio is -74.42%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock worth $25,000 after purchasing an additional 753 shares during the last quarter. LRI Investments LLC grew its stake in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA in the second quarter valued at approximately $32,000. Central Pacific Bank Trust Division bought a new position in DENTSPLY SIRONA in the 1st quarter worth approximately $64,000. Finally, GAMMA Investing LLC lifted its holdings in DENTSPLY SIRONA by 133.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier's stock worth $67,000 after buying an additional 1,422 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.